Finding the one: How to choose a Clinical Partner in Sea of Service Providers
Publié le
What should companies look for when selecting a CRO clinicalpartner? Just one in ten drug candidates are successful in clinical…
Publié le
What should companies look for when selecting a CRO clinicalpartner? Just one in ten drug candidates are successful in clinical…
Publié le
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology….
Publié le
IDDI Complimentary Webinar on Minimization LEARN ON: Minimization method including demonstration of some of the advantages of minimization over permuted…
Publié le
Transforming statistical data into a surrogate endpoint can enable comprehension of trial results sooner than usual, but few make the…
Publié le
IDDI in collaboration with Roche have identified why using disease-free survival as a primary endpoint in early breast cancer is…
Publié le
Free Webinar on Expansion Cohorts in Early Development of Anticancer Agents In this webinar we reviewed: The recent literature related…
Publié le
Free Live Webinar: Assessing Treatment Benefit in Immuno-Oncology In this webinar we reviewed key issues related to endpoints in immuno-oncology,…
Publié le
Oncology Clinical Trials We wish to draw your attention on the publication of a valuable book Oncology Clinical Trials –…
Publié le
IDDI sponsor and speaker at 6th Oncology Strategy Meeting USA 2018. Join us! Marc Buyse Chief Scientific Officer IDDI will give…
Publié le
Join IDDI at the Oncology Strategy Meeting. IDDI is an oncology CRO led by a highly-skilled biostatistical and clinical team of…